Intrauterine Devices (IUD) Market 2024-2032: Global Industry Analysis, Share, Size, Growth and Forecast

IMARC Group’s report titled “Intrauterine Devices (IUD) Market Report by Product (Hormonal Intrauterine Device, Copper Intrauterine Device), End-Use (Hospitals, Gynaecology Clinics, Community Healthcare, and Others), and Region 2024-2032“. The global intrauterine devices market size reached US$ 4.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.6 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032. 

Factors Affecting the Growth of the Intrauterine Devices Industry:

  • Long Term Efficiency:

IUDs are known for being cost-effective and reliable over a long period of time, making them a popular choice for extended contraception. Once inserted, IUDs can offer protection against pregnancy for five to ten years, depending on the type. Their one-time expense and extended effectiveness make them financially appealing, especially in low to middle-income countries where long important. Furthermore, the lasting nature of IUDs reduces the need for frequent healthcare visits for contraception, which can be both costly and time-consuming. This aspect is especially significant in areas with limited healthcare access, leading to the increased use of IUDs.

  • Increasing Awareness About Reproductive Health:

Increased awareness and education about reproductive health are major factors influencing the global market for intrauterine devices (IUDs). Governments and non-governmental organizations worldwide are placing greater emphasis on health education programs that cover different contraceptive options, including IUDs. By providing comprehensive information, counseling, and accessible healthcare services, these initiatives aim to dispel myths and misconceptions about IUDs, such as concerns about infertility or serious side effects, thus encouraging their adoption. Educational campaigns targeting both genders are also instrumental in fostering a shared understanding and backing for family planning methods, ultimately fostering wider acceptance and demand for IUDs.

  • Technological Advancements:

The growth of the intrauterine device market is driven by ongoing technological progress and improvements in product design. Recent models of IUDs are engineered to be more efficient, with reduced risks of complications and adverse reactions. Innovations like the introduction of hormone-releasing IUDs provide added benefits such as decreased menstrual bleeding and pain, which are desirable qualities for many users. These advancements improve the overall safety and effectiveness of IUDs, making them more appealing to women seeking dependable and reversible contraceptive options. The creation of smaller, more flexible IUDs has also enhanced comfort and ease of insertion, making them suitable for a wider range of women, including those without children, thus expanding the potential customer base.

Leading Companies Operating in the Global Intrauterine Devices Industry:

  • Actavis
  • Bayer
  • Teva Pharmaceuticals
  • Allergan
  • ANI Pharmaceuticals 
  • Eurogine
  • OCON Medical
  • Pregna
  • SMB Corporation 
  • HLL Lifecare 
  • HRA Pharma
  • Besins HealthCare

For an in-depth analysis, you can refer sample copy of the report:

Intrauterine Devices Market Report Segmentation:

By Product:

  • Hormonal Intrauterine Device
  • Copper Intrauterine Device

Hormonal intrauterine devices (IUD) accounts for the largest market share due to their high effectiveness in preventing pregnancies, which makes them a reliable choice for many.

By End Use:

  • Hospitals
  • Gynaecology Clinics
  • Community Healthcare
  • Others

Based on the end use, the market has been divided into hospitals, gynaecology clinics, community healthcare, others.

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Global Intrauterine Devices Market Trends:

Currently, hormonal intrauterine devices (IUDs) that release pro are becoming more popular because of their effectiveness, convenience, and menstrual advantages. Women are opting for hormonal IUDs more and more due to their lesser menstrual bleeding and cramping, as well as their superior contraceptive properties in comparison to non-hormonal copper IUDs. Additionally, healthcare professionals are endorsing the use of IUD insertions immediately after childbirth or abortion as safe and efficient contraceptive choices. Prompt insertion of IUDs following delivery or termination of pregnancy lowers the chances of unintended pregnancies and assists women in starting contraception during a crucial period, enhancing family planning results.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:


134 N 4th St. Brooklyn, NY 11249, USA


Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 |United Kingdom: +44-753-713-2163

Share your love
Articles: 137

Leave a Reply